Abstract: Breast conservation therapy (BCT) has evolved as a favorable approach to the management of early-stage breast cancer. Shortcomings of BCT include the potential need for re-excision in the event of positive tumor margins as well as the untoward sequelae of radiation therapy. Both of those factors have led to a substantial proportion of patients undergoing BCT who ultimately report suboptimal aesthetic outcomes. Application of plastic surgery principles to the management of this patient subset has been shown to be beneficial from both an oncologic and cosmetic perspective.
S
ince the 1970s, breast conservation therapy (BCT), consisting of lumpectomy and adjuvant breast radiation therapy, has gained popularity and acceptance among oncologic surgeons. Studies have shown BCT to have similar long-term survival rates compared with mastectomy, albeit with a local recurrence rates as high as 8.8% to 14.3%. 1, 2 The balance between achieving adequate surgical margins while preserving breast cosmesis results in a significant percentage of women requiring multiple operations for re-excision of positive margins, particularly in women with smaller breast volume preoperatively. This increases the anxiety related to concerns for future recurrence and leaves up to 30% to 40% of women dissatisfied with their cosmetic outcome (Fig. 1) , leading to elective mastectomy with breast reconstruction in a certain percentage of women. [3] [4] [5] As more than half of the estimated 200,000 women diagnosed with breast cancer in the United States each year are undergoing BCT, there are up to 40,000 women, annually, who may be unhappy with the appearance of their breast after completion of therapy. 6 The purpose of this study is to better identify breast cancer patients who may benefit from the involvement of a plastic surgeon before initiation of BCT by oncologic surgeons.
METHODS
An institutional review board-approved retrospective review was performed for 762 women with a diagnosis of breast cancer who underwent lumpectomy at Wake Forest Baptist Health between January 1999 and December 2009. Patients undergoing surgery for benign disease were excluded from the study population. The pathologic diagnosis, tumor size, location, margin status, number of re-excisions, recurrence, subsequent mastectomy, and breast reconstruction type, if applicable, were analyzed. Statistical comparisons between study groups were performed using analysis of variance for continuous variable and regression analysis.
RESULTS
Of the 762 women undergoing lumpectomy during the 10-year study period, there were a total of 541 (71.0%) women who underwent BCT for a diagnosis of malignant breast cancer. Patient ages ranged from 27 to 99 years (mean, 61.3 years), with an average follow-up period of 5.0 years (8 months to 12.5 years). Invasive ductal adenocarcinoma was the most common type of breast cancer (Fig. 2) . The most common location of tumor was upper outer quadrant (60.0%), and the average size of the tumor was 16.2 mm (range, 5-65 mm). The overall rate of subsequent re-excision for positive margins was 18.5% (Fig. 3) . Tumor location and body mass index were not found to correlate with the need for re-excision. There was a significant difference in the mean tumor size for women undergoing re-excision for positive margins, 19.7 mm, compared with 16.2 mm for all women diagnosed with breast cancer, P ϭ 0.02 (Fig. 4) .
Nearly 35% of those patients requiring re-excision subsequently underwent completion mastectomy, compared with the overall completion mastectomy rate of 14.4% in the general study population undergoing BCT (Fig. 5) . Fear of recurrence and poor cosmesis were the two most commonly reported contributing factors in the decision for the patient to proceed to completion mastectomy (Fig. 6 ). Those patients electing to undergo completion mastectomy for fear of recurrence were significantly younger compared with the general study population (mean age, 58.2 vs. 61.3 years; P ϭ 0.01). Overall, women younger than 60 years were 59% more likely to undergo completion mastectomy than women older than 60 years (P Ͻ 0.001). In those women who underwent completion mastectomy, the majority (60.3%) underwent breast reconstruction surgery (Fig. 7) . A plastic surgeon was consulted for only 1.6% of women before initiation of BCT and 7.6% of patients after completion of BCT.
DISCUSSION
The field of oncoplastic surgery has emerged from the increasing trend toward BCT and the recognized need to improve the aesthetic outcomes of this approach in the management of breast cancer. There have been multiple publications proposing algorithms for the reconstruction of partial mastectomy techniques. [7] [8] [9] It is recognized that the 2 general options for reconstruction after lumpectomy are categorized as volume displacement and volume replacement, 8 -11 determined by patient-specific factors such as tumor size, location, and breast volume. Tumors located in the inferior and inner quadrants or retroareolar position, as well as specimen volume greater that 10% to 20% of overall breast volume, are commonly cited as features that portend a poor cosmetic outcome in BCT. 12, 13 Given the deleterious effects of radiation therapy, the identification of patients who would benefit from involvement of a plastic surgeon to implement oncoplastic techniques would prove beneficial in a large percentage of women who would otherwise go on to have suboptimal aesthetic outcomes. In addition, integration of oncoplastic principles has been shown to also improve oncologic outcomes, as the extirpative surgeon may apply wider margins in resection of the tumor compared with standard lumpectomy. 14 The ideal timing of reconstruction after BCT remains a matter of debate. Delayed reconstruction ensures negative margins before reconstruction; however, previous studies have demonstrated poorer aesthetic outcomes in those women undergoing delayed reconstruction. 8 Therefore, the ability to more accurately predict which patients would benefit from an oncoplastic approach to BCT would be of great utility. The results of this study indicate that a significant number of women (18.5%) required re-excision for positive margins after lumpectomy, which was associated with an increased tendency toward completion mastectomy. Preoperative tumor size approaching 2 cm was a significant predictor for the need to undergo re-excision, and younger women were significantly more likely to ultimately undergo completion mastectomy. Those findings correlate with previous studies, in which younger patients were significantly more likely to have a poor cosmetic outcome. 5 In this study, plastic surgery consultation was obtained in only 1.6% of patients before BCT and 7.6% of patients after BCT. However, the majority of women who underwent completion mastectomy subsequently underwent breast reconstruction. This suggests that the involvement of a plastic surgeon earlier in the surgical planning process may be of substantial benefit in this patient population.
CONCLUSIONS
BCT remains an appropriate treatment for breast cancer, with a relatively low rate of progression to mastectomy. However, the need for repeat operations for positive margins remains significantly high, particularly for larger tumors. In addition, a small percentage of women do subsequently undergo a completion mastectomy after BCT for fear of recurrence, positive margins, or a suboptimal aesthetic outcome. Plastic surgeons may play a key role in preoperative planning for BCT in younger women and patients with larger tumors to help minimize the need for re-excision procedures and completion mastectomy, while ensuring optimal aesthetic results.
